SEDY FILL 80CC: Clinical Specifications & Data Sheet

SEDY FILL 80CC is a high-volume, monophasic, cross-linked hyaluronic acid (HA) dermal filler engineered for macro-volumization. Manufactured via bio-fermentation, it utilizes a proprietary HENM (High Efficiency Network Macromolecule) cross-linking technology to maximize the viscoelastic profile required for deep tissue body contouring.

Quantitative Composition & Physical Properties

Clinical Application Protocol

This device mandates administration exclusively by licensed medical practitioners trained in advanced subcutaneous and supraperiosteal injection techniques. Strict adherence to aseptic protocols is required.

SEDY FILL 80CC is an Rx-only medical device. Administration by unauthorized personnel poses severe health risks.

Contraindications: Do not administer to patients with documented hypersensitivity to hyaluronic acid, Gram-positive bacterial proteins, or lidocaine. Absolute contraindications include localized active skin inflammation/infection, autoimmune disorders, uncontrolled systemic diseases, coagulation defects, and pregnancy or lactation. Do not inject into the intravascular space, intramuscular tissue, or highly vascularized facial areas. Extravascular injection must be confirmed prior to extrusion to prevent vascular occlusion.

Post-Procedural Management: Prohibit intense physical exertion, exposure to extreme thermal changes (sauna, cryotherapy), and excessive mechanical pressure on the augmented area for a minimum of 14 days post-administration. Immediate medical intervention is mandatory upon signs of ischemia, severe edema, or prolonged erythema.